BOPENGI Trademark

Trademark Overview


On Thursday, August 31, 2017, a trademark application was filed for BOPENGI with the United States Patent and Trademark Office. The USPTO has given the BOPENGI trademark a serial number of 79221477. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, October 18, 2024. This trademark is owned by NOVARTIS AG. The BOPENGI trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pre...
bopengi

General Information


Serial Number79221477
Word MarkBOPENGI
Filing DateThursday, August 31, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, October 18, 2024
Registration Number5435746
Registration DateTuesday, April 3, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2018

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 18, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, December 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 23, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, November 30, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, December 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 6, 2017ASSIGNED TO EXAMINER
Wednesday, December 27, 2017NOTICE OF PUBLICATION
Wednesday, January 10, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, January 16, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 3, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, May 3, 2018GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Monday, May 7, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 25, 2018NOTIFICATION PROCESSED BY IB
Friday, October 18, 2024CANCELLED SECTION 71
Monday, May 7, 2018FINAL DISPOSITION PROCESSED
Tuesday, December 12, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, January 10, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Saturday, January 27, 2018NOTIFICATION PROCESSED BY IB